Status:
COMPLETED
Genetic Risks for Bicuspid Aortic Valve Disease
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Bicuspid Aortic Valve
Unicuspid Aortic Valve
Eligibility:
All Genders
18+ years
Brief Summary
Bicuspid Aortic Valve (BAV) is the most common congenital heart malformation in adults, but very little is known about the genetic causes or risk factors for adverse outcomes. Currently, it is estimat...
Detailed Description
To be included in the study, patients must have a bicuspid or unicuspid aortic valve, documented by clinical history or imaging studies. If the aortic valve was replaced surgically, they may still be ...
Eligibility Criteria
Inclusion
- At least 18 years of age
- Diagnosis of bicuspid or unicuspid aortic valve
Exclusion
- Less than 18 years of age
- Recognized syndrome or identified genetic mutation
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 19 2022
Estimated Enrollment :
454 Patients enrolled
Trial Details
Trial ID
NCT01823432
Start Date
March 1 2012
End Date
September 19 2022
Last Update
September 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Health Science Center Houston
Houston, Texas, United States, 77030